A Tool to Predict the Probability of Intracerebral Recurrence or New Cerebral Metastases After Whole-brain Irradiation in Patients with Head-and-Neck Cancer.

Abstract:

BACKGROUND/AIM:Patients with metastatic head-and-neck cancer require individual therapies facilitated by prognostic tools. A tool to estimate the risk of recurrent or new cerebral metastases following whole-brain irradiation (WBI) is presented. PATIENTS AND METHODS:Age, gender, performance status, cancer site, number of cerebral lesions, extracerebral metastases, and time between cancer diagnosis and treatment of cerebral metastases were evaluated for intracerebral control in 23 patients. For characteristics showing a trend (p<0.07), points for these characteristics were created by dividing 6-month intracerebral control rates by 10. Patient scores were obtained by adding these points. RESULTS:Better intracerebral control was significantly associated with oropharyngeal and laryngeal cancer (p=0.014). Absence of extra-cerebral metastases (p=0.069) and longer time between cancer diagnosis and treatment of cerebral metastases (p=0.053) showed trends. Three groups were identified, namely with 3-11, 13-18 and 20-24 points. Six-month intracerebral control rates were 0%, 50% and 100% (p=0.003), respectively, for these groups. CONCLUSION:A new tool was created to predict intracerebral control following WBI and should contribute to personalization of treatment for patients with cerebral metastases of head-and-neck cancer.

journal_name

Anticancer Res

journal_title

Anticancer research

authors

Staackmann C,Janssen S,Schild SE,Rades D

doi

10.21873/anticanres.12714

subject

Has Abstract

pub_date

2018-07-01 00:00:00

pages

4199-4202

issue

7

eissn

0250-7005

issn

1791-7530

pii

38/7/4199

journal_volume

38

pub_type

杂志文章
  • Telomerase activity in thyroid neoplasms evaluated by the expression of human telomerase reverse transcriptase (hTERT).

    abstract:BACKGROUND:The recent availability of a monoclonal antibody against human telomerase reverse transcriptase (hTERT) has enabled us to investigate the telomerase activity of tissue specimens more easily than by classical TRAP assay. In this study, we studied teromerase activity in thyroid tumors using this antibody. MAT...

    journal_title:Anticancer research

    pub_type: 杂志文章

    doi:

    authors: Ito Y,Yoshida H,Tomoda C,Uruno T,Takamura Y,Miya A,Kobayashi K,Matsuzuka F,Kuma K,Miyauchi A

    更新日期:2005-01-01 00:00:00

  • Induction of apoptosis by epigallocatechin gallate and autophagy inhibitors in a mouse macrophage-like cell line.

    abstract::We have previously reported that lignin carbohydrate complex and E. coli lipopolysaccharide (LPS), but not their precursors or (-)-epigallocatechin-3-gallate (EGCG), enhanced the nitric oxide (NO), citrulline and asparagines production by the mouse-macrophage-like cell line Raw264.7. Here the EGCG inhibition of NO pro...

    journal_title:Anticancer research

    pub_type: 杂志文章

    doi:

    authors: Hashimoto K,Sakagami H

    更新日期:2008-05-01 00:00:00

  • Topotecan-induced long-term remission of an advanced endometrial cancer after treatment with cisplatinum, an anthracycline and paclitaxel.

    abstract:BACKGROUND:The optimal palliative chemotherapy in endometrial cancer is unknown. CASE REPORT:A patient was diagnosed to have primary endometrioid endometrial cancer metastatic to the pelvic, paraaortic and right inguinal lymph nodes (FIGO IVb). After radical surgery, she received 6 adjuvant cycles of cisplatin and epi...

    journal_title:Anticancer research

    pub_type: 杂志文章

    doi:

    authors: Idris T,Winter R,Lang U,Petru E

    更新日期:2009-05-01 00:00:00

  • Induction of apoptosis and G2/M arrest by 2-methoxyestradiol in human cervical cancer HeLaS3 cells.

    abstract:BACKGROUND:It has been demonstrated that 2-Methoxyestradiol (2-ME), one of the estrogen metabolites, induces apoptosis in many different tumor cell lines. In the present study, the effects of 2-ME on human cervical cancer HeLaS3 cells and on normal cervical epithelial cells were evaluated. MATERIALS AND METHODS:Acridi...

    journal_title:Anticancer research

    pub_type: 杂志文章

    doi:

    authors: Li L,Bu S,Bäckström T,Landström M,Ulmsten U,Fu X

    更新日期:2004-03-01 00:00:00

  • The Role of Prophylactic Cranial Irradiation for Non-small Cell Lung Cancer.

    abstract:BACKGROUND:The use of prophylactic cranial irradiation (PCI) to treat brain metastases (BM) in non-small cell lung cancer (NSCLC) is restricted due to the potential associated toxicity and lack of survival benefit. BM can have a negative impact on neurocognitive function (NF) and quality of life (QOL). The aim of this ...

    journal_title:Anticancer research

    pub_type: 杂志文章,评审

    doi:10.21873/anticanres.12185

    authors: Precival C,Landy M,Poole C,Mullaney L

    更新日期:2018-01-01 00:00:00

  • Developing a decision-making model based on an interdisciplinary oncological care group for the management of colorectal cancer.

    abstract:AIM:To report our experience on implementation and preliminary results of a decision-making model based on the recommendations of an Interdisciplinary Oncological Care Group developed for the management of colorectal cancer. PATIENTS AND METHODS:The multidisciplinary team identified a reference guideline using apprais...

    journal_title:Anticancer research

    pub_type: 杂志文章

    doi:

    authors: Genovesi D,Mazzilli L,Trignani M,DI Tommaso M,Nuzzo A,Biondi E,Tinari N,Martino MT,Innocenti P,DI Sebastiano P,Mazzola L,Lanci C,Neri M,Laterza F,Marino M,Ferrini G,Spadaccini A,Filippone A,DI Giandomenico E,Marulli

    更新日期:2014-05-01 00:00:00

  • The effects of cytosine arabinoside and GM-CSF in leukemic cells in vitro.

    abstract::An in vitro pilot study was conducted of the possible utility of combining low doses of cytosine arabinoside (araC) and GM-CSF to stimulate leukemic cell differentiation. Cytosine arabinoside induced macrophage differentiation in some cultures but only when the drug produced substantial cytostatic effects. GM-CSF, whe...

    journal_title:Anticancer research

    pub_type: 杂志文章

    doi:

    authors: Gao XZ,Yin MY,Preisler HD

    更新日期:1989-07-01 00:00:00

  • Inhibition of protein synthesis by monoclonal anti-idiotypic antibody-ricin A chain conjugates in MOPC 315 myeloma cells.

    abstract::Three monoclonal antiidiotypic antibodies (AIA) to MOPC 315 IgA, G3 (IgG2b), A2 (IgG1) and D10 (a hybrid molecule consisting of gamma 1 and gamma 2a heavy chains), were characterized with respect to their binding constants (Ka) to MOPC 315 mouse myeloma cells. The Ka of G3 and A2 was 10(8)/mole; and that of D10 was 3 ...

    journal_title:Anticancer research

    pub_type: 杂志文章

    doi:

    authors: Marks A,Baumal R,Lei M,Ahmad A,Liu E

    更新日期:1985-07-01 00:00:00

  • CYP2C9 polymorphisms in human tumors.

    abstract::The oxazaphosphorines cyclophosphamide (CP) and ifosfamide (IF) are alkylating agents that require bioactivation via cytochrome (CYP) P450 isoenzymes including CYP2C9 enzymes. The present study investigated CYP2C9 in regard to its allelic variants in 23 tumor samples (10 breast tumors, 1 breast tumor cell line, 5 brai...

    journal_title:Anticancer research

    pub_type: 杂志文章

    doi:

    authors: Knüpfer H,Stanitz D,Preiss R

    更新日期:2006-01-01 00:00:00

  • Malignant melanoma of soft tissues (clear cell sarcoma) of the foot. Is MRI able to perform a specific diagnosis? Report of one case and review of the radiological literature.

    abstract::The magnetic resonance (MR) findings in malignant melanoma of soft tissues, also called clear cell sarcoma of tendons and aponeuroses, have been described as a focal abnormality with a specific MR pattern of increased signal intensity (relative to normal muscle) on T1 weighted sequences and variably decreased signal i...

    journal_title:Anticancer research

    pub_type: 杂志文章,评审

    doi:

    authors: Gandolfo N,Martinoli C,Cafiero F,Peressini A,Nicolò M,Dellachà A,Derchi LE

    更新日期:2000-09-01 00:00:00

  • Differential spheroid formation by oral cancer cells.

    abstract::Squamous cell carcinomas (SCC) make up 96% of all oral cancers. Most laboratory SCC studies grow cells as a monolayer, which does not accurately represent the disease in vivo. We used a more relevant multicellular spheroid (MCS) model to study this disease. The SCC9β6KDFyn cell line, which expresses full-length β6 and...

    journal_title:Anticancer research

    pub_type: 杂志文章

    doi:

    authors: Lee C,Lee C,Atakilit A,Siu A,Ramos DM

    更新日期:2014-12-01 00:00:00

  • Differential Akt signalling in non-seminomatous testicular germ cell tumors.

    abstract:AIM:To investigate the protein kinase B (Akt) signalling proteins phosphatase and tensin homolog (PTEN), phosphorylated-Akt (p-Akt) and cyclin-dependent kinase inhibitor 1B (p27(Kip1)) in non-seminomatous germ cell tumors (NST) with a view to future investigative approaches. MATERIALS AND METHODS:The expressions of PT...

    journal_title:Anticancer research

    pub_type: 杂志文章

    doi:

    authors: Hennenlotter J,Amend B,Vogel U,Renninger M,Springer C,Kuehs U,Stenzl A,Bedke J

    更新日期:2011-11-01 00:00:00

  • PCR and flow cytometric analysis of paclitaxel-inhibited arylamine N-acetyltransferase activity and gene expression in human osteogenic sarcoma cells (U-2 OS).

    abstract::Human epidemiological studies suggest an association between N-acetyltransferase (NAT) activity and the incidence of bladder and colorectal cancers. In this study, paclitaxel was selected to examine the inhibition of arylamine NAT activity, gene expression and 2-aminofluorene-DNA adduct formation in a human osteogenic...

    journal_title:Anticancer research

    pub_type: 杂志文章

    doi:

    authors: Lu KH,Wang DY,Lue KH,Hsiao YM,Chou MC,Chen YS,Chung JG

    更新日期:2004-01-01 00:00:00

  • Evaluation of a selective prostaglandin E receptor EP1 antagonist for potential properties in colon carcinogenesis.

    abstract:BACKGROUND:Cyclooxygenases (COXs) and prostanoids play pivotal roles in colon carcinogenesis. This study was designed to determine the chemopreventive effects of ONO-8711, a selective prostaglandin E receptor EP1 antagonist, on the development of azoxymethane (AOM)-induced colonic aberrant crypt foci (ACF) in male F344...

    journal_title:Anticancer research

    pub_type: 杂志文章

    doi:

    authors: Kawamori T,Uchiya N,Kitamura T,Ohuchida S,Yamamoto H,Maruyama T,Sugimura T,Wakabayashi K

    更新日期:2001-11-01 00:00:00

  • Multicyclic dose-intensive chemotherapy supported by autologous blood progenitor cell transplantation for relapsed small cell lung cancer.

    abstract::We report two cases with small cell lung cancer (SCLC) receiving multicyclic dose-intensified chemotherapy (DI-CT) supported by autologous blood progenitor cell transplantation (ABPCT). Both cases were initially treated with cisplatin (CDDP), etoposide (ETP) and concurrent thoracic irradiation, however they had recurr...

    journal_title:Anticancer research

    pub_type: 杂志文章

    doi:

    authors: Fujimoto N,Ueoka H,Kiura K,Tabata M,Bessho A,Takata I,Sunami K,Hiramatsu Y,Ikeda K,Tanimoto M,Harada M

    更新日期:2003-09-01 00:00:00

  • Cancer chemotherapy chemosensitivity testing is useful in evaluating the appropriate adjuvant cancer chemotherapy for stages III/IV gastric cancers without peritoneal dissemination.

    abstract:BACKGROUND:Because of the low chemosensitivity of gastric cancer to conventional antitumor agents, the role of adjuvant chemotherapy for patients with advanced gastric cancer is controversial. We have previously proposed the necessity to evaluate the appropriateness of particular adjuvant cancer chemotherapies in indiv...

    journal_title:Anticancer research

    pub_type: 杂志文章

    doi:

    authors: Kubota T,Egawa T,Otani Y,Furukawa T,Saikawa Y,Yoshida M,Watanabe M,Kumai K,Kitajima M

    更新日期:2003-01-01 00:00:00

  • Cisplatin enhances interaction between p66Shc and HSP27: its role in reorganization of the actin cytoskeleton in renal proximal tubule cells.

    abstract:BACKGROUND/AIM:Cisplatin nephrotoxicity includes early activation of the pro-apoptotic p66Shc and disorganization of the actin cytoskeleton, integrity which is regulated by heat-shock protein-27 (Hsp27). Here we determined the potential role of p66Shc in abrogating the Hsp27 function. MATERIALS AND METHODS:Effects of ...

    journal_title:Anticancer research

    pub_type: 杂志文章

    doi:

    authors: Arany I,Clark JS,Reed DK,Ember I,Juncos LA

    更新日期:2012-11-01 00:00:00

  • Lysozyme is up-regulated in columnar-lined Barrett's mucosa: a possible natural defence mechanism against Barrett's esophagus-associated pathogenic bacteria.

    abstract:BACKGROUND:Lysozyme is a natural antimicrobial enzyme that is up-regulated in inflammatory diseases of the gastrointestinal tract. Pathogenic microbes have recently been identified in the esophageal mucosa in patients with Barrett's esophagus (BE). Lysozyme expression was evaluated in biopsies from patients with BE. M...

    journal_title:Anticancer research

    pub_type: 杂志文章

    doi:

    authors: Rubio CA

    更新日期:2012-11-01 00:00:00

  • In vitro evaluation of targeted antisense 177Lu radiotherapy.

    abstract:BACKGROUND:The BCL2 proto-oncogene in non-Hodgkin's lymphoma is a dominant inhibitor of apoptosis. The goal of this work was to develop a (177)Lu-labeled anti-BCL2-peptide nucleic acid (PNA) conjugate designed for dual modality NHL therapy, i.e., simultaneous down-regulation of BCL2-mediated resistance to apoptosis and...

    journal_title:Anticancer research

    pub_type: 杂志文章

    doi:

    authors: Balkin ER,Jia F,Miller WH,Lewis MR

    更新日期:2011-10-01 00:00:00

  • Prognostic evaluation of COX-2 expression in renal cell carcinoma.

    abstract:BACKGROUND:Prognosis of renal cell carcinoma (RCC) differs within the same stage and grade. Our aim was to investigate the incidence of COX-2 in primary RCC tumors at different stages according to the occurrence of metastasis, and the impact of this biomarker on the survival of RCC patients. PATIENTS AND METHODS:The c...

    journal_title:Anticancer research

    pub_type: 杂志文章

    doi:

    authors: Kankuri-Tammilehto MK,Söderström KO,Pelliniemi TT,Vahlberg T,Pyrhönen SO,Salminen EK

    更新日期:2010-07-01 00:00:00

  • Mutations of mitochondrial DNA as potential biomarkers in breast cancer.

    abstract:BACKGROUND:Alterations of mitochondrial DNA (mtDNA) have been found in cancer patients, therefore informative mtDNA mutations could serve as biomarkers for the disease. MATERIALS AND METHODS:The two hypervariable regions HVR1 and HVR2 in the D-Loop region were sequenced in ten paired tissue and plasma samples from bre...

    journal_title:Anticancer research

    pub_type: 杂志文章

    doi:

    authors: Cai FF,Kohler C,Zhang B,Chen WJ,Barekati Z,Garritsen HS,Lenner P,Toniolo P,Zhang JJ,Zhong XY

    更新日期:2011-12-01 00:00:00

  • Prognostic relevance of p53 in node negative breast cancer.

    abstract::In a retrospective study, immunohistochemical determinations of p53 were performed on paraffinised tissue sections of 243 patients with node negative breast cancer. These patients were primary treated in the years 1980-1986 at the UFK-Würzburg. A complete follow up could be performed in 92% of all cases. The median fo...

    journal_title:Anticancer research

    pub_type: 杂志文章

    doi:

    authors: Kristen P,Müller JG,Caffier H

    更新日期:1997-07-01 00:00:00

  • The use of bevacizumab in non-small cell lung cancer: an update.

    abstract::Lung cancer is the leading cause of cancer-related death worldwide, with approximately 1.2 million deaths annually. The standard-of-care in patients with advanced disease is platinum-based doublet chemotherapy. Recent advances in the understanding of biological mechanisms of tumor growth have allowed for identificatio...

    journal_title:Anticancer research

    pub_type: 杂志文章,评审

    doi:

    authors: Lauro S,Onesti CE,Righini R,Marchetti P

    更新日期:2014-04-01 00:00:00

  • Optimal Tumor Reduction Rate and Modalities for Predicting pCR in Women With Breast Cancer.

    abstract:BACKGROUND/AIM:To predict pCR during neoadjuvant chemotherapy is still difficult. The aim of this study was to evaluate the optimal tumor reduction rate and modalities for predicting pCR after two cycles of docetaxel. PATIENTS AND METHODS:We analyzed 52 patients with HER2-positive or triple-negative breast cancer. The...

    journal_title:Anticancer research

    pub_type: 杂志文章

    doi:10.21873/anticanres.14196

    authors: Kuba S,Maeda S,Matsumoto M,Yamanouchi K,Iwata T,Morita M,Sakimura C,Otsubo R,Yano H,Sato S,Kanetaka K,Nagayasu T,Eguchi S

    更新日期:2020-04-01 00:00:00

  • Mapping the methylation pattern by bisulfite genomic sequencing of the E-cadherin promoter CpG island in nasopharyngeal carcinoma.

    abstract:BACKGROUND:It is hypothesised that hypermethylation of the CpG island in the promoter region in several tumour suppressor genes contributes one of the mechanisms for silencing or down-regulating the expression of the tumour suppressor genes. One of the putative tumour suppressor genes, the E-cadherin gene, has shown do...

    journal_title:Anticancer research

    pub_type: 杂志文章

    doi:

    authors: Kao RH,Huang LC,Hsu YH

    更新日期:2002-11-01 00:00:00

  • PTHrP regulates angiogenesis and bone resorption via VEGF expression.

    abstract:BACKGROUND:Parathyroid hormone-related protein (PTHrP) is a key regulator of osteolytic metastasis of breast cancer (BC) cells, but its targets and mechanisms of action are not fully understood. This study investigated whether/how PTHrP (1-34) signaling regulates expression of vascular endothelial growth factor (VEGF) ...

    journal_title:Anticancer research

    pub_type: 杂志文章

    doi:

    authors: Isowa S,Shimo T,Ibaragi S,Kurio N,Okui T,Matsubara K,Hassan NM,Kishimoto K,Sasaki A

    更新日期:2010-07-01 00:00:00

  • Resumption of Trastuzumab in Patients With Disease Recurrence After (Neo-) Adjuvant Anti-HER2-therapy in Patients With HER2-positive Breast Cancer.

    abstract:BACKGROUND/AIM:HER2-positive breast cancers eventually relapse in about one third of patients. Is anti-HER2-directed therapy with Herceptin® (trastuzumab) effective in re-treatment? Between 2008 and 2018, 216 patients with recurrent HER2-positive breast cancer (BC) were re-treated with Herceptin (HER) during first-line...

    journal_title:Anticancer research

    pub_type: 杂志文章

    doi:10.21873/anticanres.14390

    authors: Hanker LC,FÖrster F,SchrÖder J,Grafe A,Hitschold T,Hesse T,Lattrich CR,Rody A

    更新日期:2020-07-01 00:00:00

  • Similar Recurrence Rate Between Gleason Score of Six at Positive Margin and Negative Margin After Radical Prostatectomy.

    abstract:BACKGROUND/AIM:To investigate whether surgical margin (SM) status would affect the biochemical recurrence (BCR) after robot-associated RP (RARP). PATIENTS AND METHODS:We evaluated BCR after RARP and the association between pre- and postoperative predictive factors and BCR. RESULTS:Positive SM (PSM) was observed in 97...

    journal_title:Anticancer research

    pub_type: 杂志文章

    doi:10.21873/anticanres.14802

    authors: Kano H,Kadono Y,Kadomoto S,Iwamoto H,Yaegashi H,Iijima M,Kawaguchi S,Nohara T,Shigehara K,Izumi K,Ikeda H,Mizokami A

    更新日期:2021-01-01 00:00:00

  • Anti-tumor effect of N-beta-alanyl-5-S-glutathionyldihydroxyphenylalanine (5-S-GAD), a novel anti-bacterial substance from an insect.

    abstract:PURPOSE:We examined the anti-tumor effect of 5-S-GAD, a novel potent inhibitor of protein tyrosine kinases, isolated from the flesh fly in order to investigate the potential use of this compound as an anti-tumor agent. METHODS:In vitro growth inhibition was evaluated using the alamarBlue assay kit. In vivo anti-tumor ...

    journal_title:Anticancer research

    pub_type: 杂志文章

    doi:

    authors: Akiyama N,Hijikata M,Kobayashi A,Yamori T,Tsuruo T,Natori S

    更新日期:2000-01-01 00:00:00

  • Tumor-specific cytotoxicity and type of cell death induced by beta-cyclodextrin benzaldehyde inclusion compound.

    abstract::The cytotoxicity of beta-cyclodextrin benzaldehyde inclusion compound (CDBA) against human normal and cancer cell lines was investigated. CDBA showed slightly higher cytotoxicity against human tumor cell lines, as compared to normal cells, with a tumor-specificity index of 2.2. Human myelogenous leukemia cell lines (H...

    journal_title:Anticancer research

    pub_type: 杂志文章

    doi:

    authors: Liu Y,Sakagami H,Hashimoto K,Kikuchi H,Amano O,Ishihara M,Kanda Y,Kunii S,Kochi M,Zhang W,Yu G

    更新日期:2008-01-01 00:00:00